NORTON META TAG

Showing posts with label flu. Show all posts
Showing posts with label flu. Show all posts

22 June 2025

8 Vaccines You Need After 50 — and 1 to Consider 11JUN25



 SINCE we can't count on that lunatic Sec of Health and Human Services fascist fotze robert f kennedy jr for honest, safe and reliable science based healthcare advise I am sharing this from AARP. What you do with it is your choice of course.....

8 Vaccines You Need After 50 — and 1 to Consider


It’s not just babies and youngsters who need a poke to protect against serious and potentially lethal diseases. Adults need shots too, especially as our immune systems weaken with age.

In fact, there are several vaccines needed after the age of 50, including some that are relatively new, like the RSV vaccine, says Morgan Katz, M.D., an associate professor of medicine at Johns Hopkins University School of Medicine.
Below are the vaccinations every adult needs, followed by two, for hepatitis A and B, that you need only if you have certain risk factors.

What won’t you see on the list? The chicken pox vaccine, since most adults already have immunity from childhood exposure to the disease, Katz says.

“Almost all adults over 40 have been exposed to chicken pox,” she says, noting that it would be “an extremely rare case” for an adult not to have been. That said, if you think you could be in that tiny minority, ask your doctor about getting the chicken pox vaccine as an adult.

For the rest of the list, you can get your necessary shots at doctors’ offices, pharmacies, workplaces, community health clinics and other locations. And most health insurance plans will pick up the tab, so stop in and let ‘em stick it to you. 

1. Influenza vaccine 
Who needs it: All adults, no matter the age.

How often: Once a year, usually in the fall. “The virus itself changes every year,” Katz says. “Researchers try to predict what will be the most common strain that season, then reformulate the vaccine accordingly.” Flu season typically begins in October and ends in March, so the CDC recommends rolling up your sleeve by the end of October, since it takes about two weeks after a vaccination for flu-fighting antibodies to develop in the body. 

What you need: Adults 65 and older should make sure they receive a high-dose version of the shot. The options include:

Fluzone High-Dose Quadrivalent is an injectable vaccine that contains four times the antigen (the flu proteins that our immune system recognizes and attacks) of a standard-dose inactivated flu vaccine, to help create a stronger immune response.
Fluad Quadrivalent is an adjuvanted flu vaccine, made with an MF59 adjuvant, an additive that creates a more robust immune response.
Flublok Quadrivalent. This is a recombinant vaccine, which means it does not require an egg-grown virus and does not use chicken eggs in the manufacturing process. This may be a good option if you are allergic to eggs (the Fluzone and Fluad offerings are grown in eggs). Flublok Quadrivalent contains three times the antigen of other standard-dose inactivated flu vaccines.

Why you need it: Each year, the flu is to blame for hundreds of thousands of hospitalizations and tens of thousands of deaths, and older adults are at higher risk for these serious outcomes. Fifty to 70 percent of flu-related hospitalizations occur among people 65 and older, according to the CDC, and 70 to 85 percent of flu-related deaths occur among this age group.

Talk to your doctor if: You’ve had a severe reaction to the flu shot in the past, are allergic to eggs, have (or have had) Guillain-Barré syndrome or have a fever. (In that case, you’ll likely be asked to wait until your temp is back to normal before you get the vaccine.)

Do you need a measles vaccine?
Measles outbreaks throughout the U.S. are causing many older adults to wonder whether they need a measles shot. The answer: You may.

Who doesn’t need one? The CDC says you don’t need a measles vaccine if you were born before 1957 or if you have had two doses of the MMR (measles, mumps and rubella) vaccine.

Who may need one? Health experts say people vaccinated before 1968 and those vaccinated between 1968 and 1989 may need an additional dose of MMR since they may have been given a less effective measles vaccine or may have only received one dose of MMR.

Talk to your doctor if you are unsure of your vaccination status. The CDC says there is no harm in getting another dose of the vaccine, even if you have prior immunity. 

Parting shot: Even if you’re vaccinated, there’s a possibility you could get the flu. How well the inoculation protects depends on different factors, including your age and health status. That said, a flu vaccination may lessen the severity of illness if you do get sick. Research, including a study published in 2024, finds that flu vaccination ​reduces flu-related hospitalizations and deaths, including among older adults.

2. COVID-19 vaccine  
Who needs it: It’s recommended for most adults 18 and older (parents of children ages 6 months to 17 years can get the vaccine in discussion with their doctor), and especially for people 65 and older, who are at increased risk for complications from a coronavirus infection.

How often: Health officials haven’t set a schedule for COVID-19 vaccines, but it’s likely the shot will become an annual one for some people at least, much like the flu vaccine. Adults 65 and older, however, may need the vaccine more frequently. In 2024, health officials recommended that adults 65-plus get a second dose of the 2024-2025 COVID-19 vaccine six months after the first dose of that vaccine, making it a fall and spring vaccine for many older adults. 

What you need: An updated COVID-19 vaccine from either Moderna, Pfizer-BioNTech or Novavax.
Why you need it: COVID-19 has killed more than 1.2 million Americans since it started circulating in the U.S. and has hospitalized millions of others. It’s especially risky for older adults, who are more likely to suffer complications from an infection.

Talk to your doctor if: You’ve had a severe allergic reaction to a medication or vaccine in the past.

Parting shot: Make it easy on yourself and get your fall COVID-19 vaccine when you go in for your flu shot. Experts say there’s no need to schedule a separate appointment.

3. RSV vaccine
Who needs it: In recently updated guidance, the CDC says adults ages 75 and older should get the vaccine to protect against respiratory syncytial virus (RSV), as should people ages 60 to 74 who live in nursing homes or who have certain medical conditions that put them at increased risk for severe illness, like heart and lung disease.

How often: For now, you need to get it only once. However, the RSV vaccine is still pretty new, so recommendations could change.

What you need: Three vaccines have been approved for older adults: Arexvy, from manufacturer GlaxoSmithKline, Abrysvo, from drugmaker Pfizer, and mRESVIA, from Moderna.

Why you need it: RSV is often associated with children, but it can be especially dangerous for older adults too. Each year, it causes 60,000 to 160,000 hospitalizations and 6,000 to 10,000 deaths among adults 65 and older, according to the CDC. In clinical trials, the vaccines were found to significantly reduce the risk of serious symptoms from an infection.  

Talk to your doctor if: You’re in the 60-74 age range and are unsure whether your underlying health issues put you at greater risk for complications from an RSV infection.

Parting shot: The vaccine could be especially helpful when it comes to avoiding a fall/winter “tripledemic” — a name used to describe the convergence of flu, COVID-19 and RSV.

4. Pneumococcal vaccine
Who needs it: Healthy adults 50 and older, or adults 19-49 with certain risk factors (smoking or health problems such as chronic lung or heart disease, leukemia, lymphoma or alcoholism).

How often: Adults who haven’t received a pneumococcal vaccine should opt for either the PCV15, PCV20 or PCV21. If PCV15 is used, it should be followed by a dose of PPSV23 a year later. (If you’re immunocompromised, you may get it sooner.) 

Why you need it: Before COVID-19 came along, pneumococcal disease, which can cause pneumonia, killed more people in the U.S. each year than all other vaccine-preventable diseases combined. Young children and those over 65 have the highest incidence of serious illness, and older adults are more likely to die from it. Experts estimate PCV13 (one of the pneumococcal vaccines available) prevented more than 30,000 cases of invasive pneumococcal disease and 3,000 deaths in its first three years of use.

Parting shot: If you work around chronically ill people — say, in a hospital or nursing home — talk to your doctor about getting the vaccine, even if you’re healthy.

Find COVID-19 Vaccines in Your State
AARP's 53 state and territory COVID-19 vaccine guides can help you find vaccines near you and provide the latest answers to common questions about costs, eligibility and availability.

5. Tdap vaccine (tetanus, diphtheria, pertussis) and/or the Td booster (tetanus, diphtheria)
Who needs it: The Tdap vaccine came out in 2005, and along with protecting against tetanus and diphtheria, like the vaccine it replaced, it includes additional protection against whooping cough, also known as pertussis.

If you can’t remember ever getting this shot, you probably need it. Doing so, Katz says, can count for one of the Td boosters you’re supposed to get every 10 years. (You know the one … it’s the shot you wonder if you’re current on after you step on a rusty nail during your vacation.)

How often: Adults should receive a booster dose of either Tdap or Td (a different vaccine that protects against tetanus and diphtheria but not pertussis) every 10 years, the CDC says, or after five years if you get a severe wound or burn.

Why you need it: Due to a rise in whooping cough cases in the U.S., you really do need to be vaccinated against it, even if you’re over 65. In the first year after getting vaccinated, Tdap prevents the illness in about 7 out of 10 people who received the vaccine. 

Talk to your doctor if: You have epilepsy or other nervous system problems, had severe swelling or pain after a previous dose of either vaccine, or have (or have had) Guillain-Barré syndrome.

Parting shot: This vaccine is especially crucial for people — including parents, grandparents and childcare providers — who have close contact with children younger than 12 months.

6. Shingles (herpes zoster) vaccine
Who needs it: The CDC recommends that everyone 50 and older get the Shingrix shingles vaccine, even if they had the earlier recommended vaccine, Zostavax — which was much less effective — and even if they’ve already had shingles. 

How often: Shingrix comes in two doses, spaced two to six months apart. 

Why you need it: One in 3 people will get shingles, usually after age 50. The risk rises with age. By 85, half of adults will have had at least one outbreak. Chicken pox and shingles are caused by the same virus, varicella zoster. After a person recovers from chicken pox, this virus stays dormant for decades in the body, ready to appear when the immune system is weakened by stress, medication or disease.

This infection causes a red rash and painful blisters. About 15 percent of sufferers are left with extreme nerve pain — a condition called postherpetic neuralgia, which can last for months or years. Shingrix can protect 97 percent of people in their 50s and 60s, and 91 percent of those in their 70s and 80s. 

Talk to your doctor if: You are not feeling well or currently have shingles. There are few other reasons not to get the vaccine. 

Parting shot: Older adults should get this vaccine whether or not they remember having chicken pox as a child. Why? More than 99 percent of Americans over 40 have been exposed to the varicella zoster virus, even if they don’t recall getting chicken pox. 

7. Hepatitis A vaccine 
Who needs it: People 50 and older who are at high risk for hepatitis A, a disease of the liver. Infections result primarily from travel to another country where hepatitis A virus transmission is common, through close contact with a hepatitis A–infected individual, or recreational drug use.

How often: Once, but given in two doses over six months.

Why you need it: Hepatitis A rates in the U.S. have declined by more than 95 percent since the hepatitis A vaccine first became available in 1995. In 2016, there were an estimated 4,000 hepatitis A cases in the U.S.

Parting shot: This is a sneaky disease. You may not have any telltale signs — and the likelihood of symptoms decreases as you age.

8. Hepatitis B vaccine
Who needs it: Adults 50 and older who are at risk for contracting hepatitis B, a liver infection. Hepatitis B is transmitted when a body fluid (blood, semen, saliva) from a person infected with the hepatitis B virus enters the body of someone who is not infected. This can happen through sexual contact or contact with blood or open sores (say, from a job that exposes you to human bodily fluids) or sharing anything from a needle to a razor to a toothbrush with an infected person. Other risk factors for infection include being on kidney dialysis, traveling to countries where hepatitis B is common, or having HIV.

How often: Adults getting the vaccine need three doses — the second dose given four weeks after the first; the third dose five months after the second. There is also a combination vaccine for both hepatitis A and B called Twinrix, which is given in three doses over six months.

Why you need it: The CDC estimates that the number of new hepatitis B infections in 2021 was 13,300.

Talk to your doctor if: You have a life-threatening allergy to yeast or to any other component of the vaccine, or you are moderately or severely ill when a dose of vaccine is scheduled.

Editor’s note: This story, published March 15, 2021, has been updated to reflect new recommendations for COVID-19, flu, RSV and pneumococcal vaccinations. Barbara Stepko contributed reporting to this story.

Michelle Crouch is a contributing writer who has covered health and personal finance for some of the nation’s top consumer publications. Her work has appeared in  Reader’s Digest,  Real Simple,  Prevention,  The Washington Post and  The New York Times.

07 May 2025

RFK Jr. will order placebo testing for new vaccines, alarming health experts 1MAI25


CHIEF mengele wannabe and all his butt kissing menegele wannabes need to be injected with placebo vaccines for all the deadly diseases of the world which tested and approved vaccines exist and then wait for the results. Then whoever is left can offer their opinion if this sort of testing is prudent. 

RFK Jr. will order placebo testing for new vaccines, alarming health experts


The potential change outlined in a statement would require all new vaccines to undergo placebo testing, sparking concerns among medical experts.


The potential change outlined in a statement says all new vaccines will be required to undergo placebo testing, a procedure in which some people receive the vaccine and others receive an inert substance — such as a saline shot — before the results are compared.

“All new vaccines will undergo safety testing in placebo-controlled trials prior to licensure — a radical departure from past practices,” an HHS spokesperson told The Washington Post in response to questions about Kennedy’s comments on the measles vaccines and general vaccine policy.

Vaccines for new pathogens are often tested this way. But for well-researched diseases, such as measles and polio, public health experts say it makes little sense to do that and can be unethical, because the placebo group would not receive a known effective intervention.

HHS did not clarify how the change will be implemented and for which vaccines the testing would apply, nor did it define what the department meant by “new vaccine.” But the government indicated it wouldn’t apply to the flu vaccine, which is updated year to year and which HHS stated “has been tried and tested for more than 80 years.” In response to questions about whether other vaccines previously safety tested would be newly scrutinized, the department focused on its concerns around the coronavirus vaccine but did not address other immunizations.

Kennedy has long disparaged vaccines, said they are not adequately safety tested and previously called for placebo testing for vaccines that are approved for use.

“Secretary Kennedy is not anti-vaccine — he is pro-safety, pro-transparency, and pro-accountability,” HHS said in a statement.

The HHS statement raised concerns among medical and public health experts who said the move could be a significant shift in how the country has ensured the safety of vaccines for decades, as well as cast doubt on vaccines that are safe, effective and key to public health. The potential change comes as public trust in vaccines continues to decline amid a growing measles outbreak and worries over Kennedy’s mixed messaging about immunizations.

Medical and public health experts also expressed dismay that the testing change could require coronavirus vaccines, and potentially others, to undergo costly and, in their view, unnecessary studies that would probably limit vaccine production and access — and leave more Americans at risk of preventable disease.

“You are watching the gradual dissolution of the vaccine infrastructure in this country,” said Paul Offit, director of the Vaccine Education Center at Children’s Hospital of Philadelphia. “The goal is to make vaccines less available and less affordable.”

In recent weeks, the Trump administration has injected uncertainty into the annual process for approving an updated coronavirus shot traditionally offered in the fall, indicating there may need to be more data.

“Except for the COVID vaccine, none of the vaccines on the CDC’s childhood recommended schedule was tested against an inert placebo, meaning we know very little about the actual risk profiles of these products,” HHS said in its statement.

Vaccine and public health experts said the statement from HHS is a combination of misinformation and exaggeration or misrepresentation of scientific studies.

“To make a blanket statement like that, I think that would go against the science,” said Sean O’Leary, a pediatric-infectious-diseases physician and chair of the American Academy of Pediatrics’ committee on infectious diseases.

The move came as Kennedy urged parents this week to “do your own research” and said that “making sure the vaccines are safe” is one of his top priorities, during an interview with Phil McGraw, who is known as Dr. Phil.

Since Kennedy became HHS secretary, the department has appointed a vaccine skeptic to investigate the debunked link between vaccination and autism. Peter Marks, the nation’s top vaccine regulator, resigned under pressure. And Kennedy has not spoken as forcefully for vaccination amid an ongoing measles outbreak as the first Trump administration did.

The HHS statement and others from Kennedy casting doubt on vaccine safety are part of his long-running effort to decrease confidence in immunizations, said David Gorski, a Wayne State University School of Medicine professor of surgery and oncology and managing editor of Science-Based Medicine, which debunks misinformation in medicine.

“Instead of just an anti-vaccine activist … saying this stuff, now the federal government, HHS and FDA is now saying this stuff. That matters,” he said.

‘Undermines real transparency’

Kennedy has previously claimed that vaccine testing studies are not long enough to capture potential safety issues, although vaccines are continuously and rigorously monitored.

“A lot of the injuries that come from medication are autoimmune injuries and allergic injuries and neurodevelopmental injuries that have long diagnostic horizons or long incubation periods, so you can do the study and you will not see the injury for five years,” Kennedy said in a 2021 interview. Waiting to conduct a multiyear study as per Kennedy’s suggestion would slow the development of vaccines and their release.

Now as head of HHS, Kennedy has said he wants to restore “gold standard” science to the federal health agencies and look at the data.

“HHS is now building surveillance systems that will accurately measure vaccine risks as well as benefits — because real science demands both transparency and accountability,” an HHS spokesperson told The Post.

Medical experts dismissed the idea that a new system was needed, saying the current system adequately tracks adverse events associated with vaccines.

Sen. Bill Cassidy (R-Louisiana) received a list of commitments from Kennedy before voting to confirm the secretary. That included a commitment to work within the “current vaccine approval and safety monitoring systems” and giving a 30-day notice to the Senate health committee if the agency seeks to make changes to any federal vaccine safety monitoring programs, Cassidy said in a Feb. 4 speech on the Senate floor.

In a statement to The Washington Post Thursday, Cassidy raised concerns about HHS’s intended shift.

“The first vaccine for a disease is already proven safe through a placebo-controlled trial,” Cassidy said. “Updating that vaccine does not require a new placebo-controlled trial to determine its safety. To require a placebo group would deny those patients access to the vaccine that has already been found safe.”

“Claiming vaccines have risks the data doesn’t show or trying to overstate vaccine risks is not transparency,” said Dorit Reiss, a professor at the University of California College of the Law at San Francisco who tracks public health vaccine law. “It’s misinformation, and it undermines real transparency and informed consent.”

Additionally, many vaccines have been tested against placebos, the experts said. And while HHS said the trials would be for “new vaccines,” if Kennedy tries to test vaccines that have already been approved, such as the measles vaccine, against a placebo, that would mean in practice some children would not get vaccinated against the infectious disease while their neighbors did — a quandary that physicians say leaves them susceptible to diseases when there is a vaccine that works.

Stanley Plotkin, a pioneer in the field who developed the rubella vaccine, said that when scientists test vaccines against a new disease, they typically look for evidence that the vaccinated individuals do not get a disease, compared with those who received a placebo. This is how the coronavirus vaccines were tested, in 30,000-person trials in which half of the participants received saline shots.

But when a disease is already well understood, scientists can look for evidence that vaccines induce a biological response that has been scientifically shown to protect against the disease — what scientists call “a correlate of protection.”

In the case of diseases that cause serious illness and can even be fatal, if there are existing interventions, the use of placebos is often not considered ethical.

“Ethics must be taken into account when you set up a study,” Plotkin said. “Can I ethically agree to having people acquire the disease because they receive a placebo?”

Coronavirus vaccine in play?

The administration has taken aim at reexamining the coronavirus vaccine.

When asked by CBS News on Tuesday whether the Food and Drug Administration plans to green-light updates to the coronavirus shots, FDA Commissioner Marty Makary said the agency was “taking a look.”

“We have a bit of a public trust problem,” Makary said. “I think there’s a void of data. And I think rather than allow that void to be filled with opinions, I’d like to see some good data.”

In a statement, HHS affirmed Makary’s comments: “Using the COVID pandemic as an eternal justification for blanket approvals of new products will not happen under the leadership of Commissioner Makary.”

Additionally, the Trump administration is seeking for the drug manufacturer Novavax to commit to conducting a new clinical trial on its coronavirus vaccine after it gets approved. The company’s shot has been available under emergency use authorization and is the only vaccine that uses a more traditional protein base instead of messenger RNA — an appealing option to some who have reactions to mRNA shots.

The FDA was on track to grant full approval to the vaccine April 1, according to two people familiar with the matter who spoke on the condition of anonymity to share internal deliberations. Top Trump FDA officials told agency regulators to pause the approval, these sources said — which some vaccine experts say amounts to political interference into decisions typically made by career staff tasked with reviewing the data.

“To be clear, this is a new product that Novavax is trying to introduce to the market with a study of a different product from 2021. New products require new clinical studies,” Makary wrote Saturday in a post on X. Several vaccine experts dismiss the notion that the vaccine constitutes a new product.

Such a move would be costly and suggests a potential shift in how the agency may approach coronavirus vaccines going forward. Typically, Pfizer and Moderna get instructions from the FDA on how to update their vaccines in June. It’s unclear whether they will need to run new clinical trials for their vaccines, which would be unlikely to occur before the annual coronavirus shot in the fall.

“While we cannot comment on this specifically, we look forward to continued collaboration with the Administration and teams across HHS,” said Chris Ridley, a spokesman for Moderna.

Medical experts The Post spoke to predicted that the change by Kennedy could limit new vaccines approved under his watch, as well as slow investment by pharmaceutical companies. Ultimately, that would result in fewer vaccines available.

“It’s just not correct. They obviously don’t understand how vaccines are approved and how one obtains safety data,” said Michael Osterholm, a University of Minnesota infectious-disease expert who advised President Joe Biden’s transition team, adding that the change threatened the existence of coronavirus vaccines.

Caitlin Gilbert and Fenit Nirappil contributed to this report.

+1

More on RFK Jr. and HHS


12 February 2018

Flu Deaths Are the Latest Example of People Dying In America Simply Because They Can't Afford Medicine & This flu season has now reached pandemic levels (but it's not technically a pandemic) & Donald Trump wrongly suggests British don't love their health care system 11&9&8FEB18


EVERYBODY DESERVES HEALTH CARE, there is no good reason for anyone to die in this country because they can not afford the necessary medication or treatment. The greed of the health care insurance-pharmaceutical cabal and the hypocrisy of the Christian politicians and their supporters, adherents of alt-jesus and the gospel of greed are not good reasons. NOT MY Pres drumpf/trump is spreading lies about the British universal health care (NHS) system and has been called out for doing so by the Health Minister of the ruling conservative party ( Health minister Jeremy Hunt, who was largely blamed for the severe lack of winter funding, hit back at Trump’s remarks, writing on Twitter that not one of the marchers "wants to live in a system where 28m people have no cover." ) From AlterNet, the Washington Post and PolitiFact.....
This week a 38-year-old second grade teacher and mom in Texas named Heather Holland died of the flu after she’d delayed picking up her prescription medication because couldn’t afford the $116 copay. By Friday night, Holland's condition worsened and she was taken to the hospital and she died on Sunday morning.
This year's flu is among the deadliest ever, killing approximately 4,000 Americans per week according to the CDC.
It seems like basic common sense that in our developed, world-leader of a nation where medications and trained healthcare professionals are readily available, no one should be dying from the flu or any other illnesses just because they can’t afford to pay for basic medicine. But thanks to our disgraceful and worsening healthcare system, cases like Holland's are shamefully common in this country.
Millions of adults in the U.S. skip their medications due to the high price tags they carry according to a Harvard Healthreport, and our pharmaseutical drug prices are jacked up about three times higher than in the rest of the world. 
As various states roll out new Medicaid work requirements and lockouts,  even more lives will likley be in danger due to lack of ability to afford healthcare.
Here are three of many examples in which the high price of drugs is literally killing people in the U.S.
1. Insulin.
The high price of insulin causes many people with diabetes to stretch out their doses and gamble with their lives by going without the medicine for stretches of time. One example of this is the tragic passing of Shane Patrick Boyle who died on March 18th, 2017 of type 1 diabetes after his GoFundMe campaign to pay for the next month’s supply of the medicine fell short $50.
Lack of insulin access is an immediate life or death situation for people with type 1 diabetes, and some people with type 2 diabetes. Despite this, the price of insulin has risen unwaveringly in the last 100 years. An international surveyreleased in 2016 shows the average personal monthly cost to people with diabetes in the U.S. is $360. A single vial of Novolog insulin is priced between $14 and $300 and a vial of Humalog insulin costs $435, according to a Vice report.

2. Cancer treatment medication.
According to the average numbers, at least 1.5 million Americans will receive a cancer diagnosis in 2018, and hundreds of thousands of those people won’t be able to afford their prescribed medications.
One fairly common cancer treatment drug called Alecensa, for instance, costs more than $159,000 a year. Many others hover around that price range. A 2014 study published in The Oncologist showed a quarter of all cancer patients opted not to fill a prescription due to the cost and nearly 20 percent only filled their prescriptions partway or took less than the prescribed dosage.  
As a Kaiser Health News article which ran on NPR reported in March 2017, “the high cost of cancer medications can burden patients for years even after they finish treatment. 
“... one-third of Medicare patients who were expected to use Gleevec — a lifesaving leukemia medication that costs up to $146,000 a year — failed to fill prescriptions within six months of diagnosis, according to a December study in the Journal of Clinical Oncology.”

3. Heart disease medication.
Heart disease is the number one cause of death in the U.S., but just as with diabetes, cancer and other illnesses, heart disease patients often can’t afford the generic prescription medications to treat the disease.
The New York Times reportedin April 2017, “Studies have shown ... that 41 percent of heart attack patients don’t take their blood pressure medications.” This is not always because of cost and studies are ongoing to look into the reasons people don’t take their prescribed medicines. But cost is definitely one of the major deterrents as Dr. Bruce Bender, co-director of the Center for Health Promotion at National Jewish Health in Denver, told the Times.
A drug called Praluent and made by the company Sanofi and Regeneron Pharmaceuticals was released alongside a drug called Entresto from Novartis pharmaceutical company in 2015. Both medicines represented big improvements in heart disease treatment but their pricing came in much higher than expected, as Reuters reported.
Sanofi and Regeneron injections came in at about $14,600 per year, well above the roughly $10,000 investors had expected.
While the price of heart disease medications are typically much lower than those of cancer drugs (which tend to cost upwards of $100,000 per year), they remain prohibitive to many— especially since they are designed for lifetime use and typically purchased monthly.
April M. Short is a freelance writer who focuses on health, wellness and social justice. She previously worked as AlterNet's drugs and health editor. 
This flu season is turning out to be so intense that the number of people seeking care at doctors' offices and emergency rooms has surged to levels not reported since the peak of the 2009 swine flu pandemic, federal officials said Friday.
For yet another week, the flu continues to get worse. “We were hoping to have better news,” said Anne Schuchat, acting director of the Centers for Disease Control and Prevention.
“This does not mean we’re having a pandemic,” Schuchat said. “But it is a signal of how very intense the flu season has been. We may be on track to break some recent records.”
Pandemics occur when there is a new strain of virus for which people have no previous exposure. That's not the case here, because the seasonal strains that are circulating this year are not new. But the predominant one, H3N2, is a particularly nasty strain that is associated with more complications, hospitalizations and deaths, especially among children, those older than 65 and people with certain chronic conditions.
Another 10 children died in the week ending Feb. 2, bringing the total number of child deaths since this flu season began to at least 63. This is the number of reported deaths and probably does not include all children who have died. States are not required to report adult flu deaths.
Flu activity is still widespread across the country, the latest data show. Overall hospitalizations are also now significantly higher than what officials have normally seen this time of year since CDC began using this tracking system in 2010, Schuchat said. In particular, officials are seeing unusually high levels of hospitalizations in non-elderly adults, with the rates for 50-to-64-year-olds significantly higher than what they were at the same period in the severe 2014-2015 season with the same predominant flu strain.
The latest weekly report shows 1 out of every 13 doctor visits last week was for fever, cough and other symptoms of the flu, matching the peak levels during the 2009 swine flu pandemic. It was higher than any other seasonal flu season since 2003, when officials changed the way flu is tracked.
“We don’t have any signs of hospitalizations leveling off yet,” Schuchat said in a telephone briefing for reporters.
Concern over the deadly flu season was one reason Sen. John McCain delayed his return to Washington during key legislative deliberations, his daughter Meghan said Wednesday.
In an interview with Politico’s “Women Rule” podcast, the Arizona Republican’s daughter said her father, recovering from chemotherapy for aggressive brain cancer and a viral infection in December, is taking precautions that are keeping him in Arizona.
While the H3N2 strain, a type of influenza A virus, continues to dominate, officials are now also seeing increases in the proportion of influenza B viruses in this 11th week of the flu season.
One reason for this unusually intense flu season is probably the vaccine’s lower effectiveness against the predominant strain. Canadian researchers recently suggested the H3N2 component of the vaccine is about 17 percent effective in preventing infection.
“I wouldn’t be surprised to see something like that” for the vaccine’s effectiveness against the H3N2 in the United States, Schuchat said. But she and others have said the vaccine performs better against other strains, and is about 55 percent effective against influenza B viruses that are on the rise. Flu shots also reduce the severity of illness. CDC is expected to soon release a preliminary analysis of this season’s vaccine effectiveness.
Officials say it is not too late to get a flu shot. They don’t know how long this season will last — it has yet to reach its peak — and it is possible to get infected by flu more than once.
Angie Barwise, a 58-year-old mother and grandmother from Fort Worth, was diagnosed with the flu twice this season and died last week following complications from the illness. She had been diagnosed around the holidays with the flu, along with bronchitis and strep, her family told Fox affiliate KDFW. Her family said she had not received the vaccine.
Doctors gave her antibiotics and the antiviral medication Tamiflu, and she started to bounce back. But almost exactly a month later, her family said, she was in the emergency room with a different strain of the virus. But this time, KDFW reported, Barwise also had pneumonia and went into in septic shock, a life-threatening medical condition and a known complication of the virus, according to CDC.
On Saturday — a week after her second bout of the flu began — she died.
“I've outlived my own daughter,” her mother, Eileen Smith, told the news station this week. “I'm 83 years old, and I've outlived her. It shouldn't be that way.”
As health-care professionals scramble to combat the virus and care for people seeking treatment, there continue to be local shortages of antiviral medication, officials said. Unlike most years when flu activity starts and ends at different times and at different places across the country, virtually the entire country has been slammed with intense levels of flu at the same time, so there are more prescriptions for antiviral drugs than previous years, Schuchat said.
CDC officials are working with pharmacies, health plans and others in the health-care system to have pharmacies stock larger amounts of medicine and allow brand-name drugs to be substituted for generics, which often carry lower out-of-pocket costs for consumers.
Still, the cost of prescription antivirals has led some patients to hesitate using them, with tragic consequences.
Heather Holland, a schoolteacher from Willow Park, Tex., was recently diagnosed with the flu and prescribed the generic form of Tamiflu. But her husband, Frank, told the Wall Street Journal that once she discovered it cost her $116 under her insurance plan, she decided against it.
“It’s principle with her. She’s a very frugal person in general, always has been,” he said.
Frank Holland told the Journal that when he found out that his wife had refused to fill the prescription, he did it. “I made her start taking it,” he told the newspaper.
But Holland was not able to fight the flu — her family said she died Feb. 4, less than a week after she first started to experience symptoms of the virus.
Read more:
Lena H. Sun is a national reporter for The Washington Post, focusing on health.
  Follow @bylenasun
Lindsey Bever is a general assignment reporter for The Washington Post, covering national news with an emphasis on health.
  Follow @lindseybever

Donald Trump wrongly suggests British don't love their health care system

As thousands marched in the streets of London recently to protest funding cuts to the British National Health Service, President Donald Trump took to Twitter to criticize the idea of universal health care.
"The Democrats are pushing for Universal HealthCare while thousands of people are marching in the UK because their U system is going broke and not working. Dems want to greatly raise taxes for really bad and non-personal medical care. No thanks!"
See Figure 1 on PolitiFact.com
Trump’s Feb. 5 tweet came shortly after Nigel Farage, the former UK Independence Party leader, talked about the NHS march and universal health care on Fox & Friends, warning Americans it would be "politically impossible" to remove such a system once introduced. Trump thanked the network on Twitter for "exposing the truth" shortly after Farage’s appearance.
We wondered how accurate Trump’s claim was that people joined the NHS march because the UK’s universal health care system "is going broke and not working."
We looked at the origins of the march and recent polling statistics about British public opinion on the National Health Service, commonly called the NHS. We also looked at the current funding situation, since Trump’s claim suggests it’s losing money. We found that Trump’s tweet gives a misleading impression about how the British public feels about its health care system.
Public support for NHS
University of North Carolina health policy professor and deputy director of the Cecil G. Sheps Center for Health Services Research, Thomas C. Ricketts, told PolitiFact that the NHS probably has higher public support than any other government program in the UK.
Public support for the NHS being maintained in its current form remains high according to a poll by Ipsos; 77 percent of people support this, while 9 in 10 people think the founding principles of the NHS should still apply to services today. Two-thirds of adults are willing to pay more of their own taxes to pay for the NHS.
In a poll by YouGov last year, 84 percent of people were in favor of the service continuing to be run by the public sector.
Helen Howson, the director of the Bevan Commission, an independent think tank for health in Wales, is working to find ways to improve the system while maintaining the principles set out at its founding.
"The NHS is a service which was set up to ensure that no one would be disadvantaged on the basis of their ability to pay, and people are passionate about these principles," she said.
The NHS march, officially named, "NHS in crisis: Fix it now"  was organized by the People’s Assembly, an independent, national campaign against austerity and Health Campaigns Together, a coalition defending the NHS.
This year marks 70 years of NHS existence in the U.K., but the health care system has gone through what has been described as the worst winter in its recent history. The lack of funding is often blamed on austerity measures put forth by the Conservative Party and there have been concerns raised over privatizing parts of the system.
Trump’s comments regarding the demonstration received immediate response by British officials, such as Labour leader Jeremy Corbyn, who said people were marching because they love the NHS and hate what is being happening to it by the current party in power.
Health minister Jeremy Hunt, who was largely blamed for the severe lack of winter funding, hit back at Trump’s remarks, writing on Twitter that not one of the marchers "wants to live in a system where 28m people have no cover."
Growing concerns
This is not to say that people don’t have concerns about the NHS. In a poll released last summer by the British Medical Association, more people are unhappy with the NHS than satisfied for the first time in the public poll run by British doctors. It showed that 70 percent of people think the health service is going in the wrong direction.
The poll shows that 43 percent of respondents are dissatisfied with the service, which is double the number of dissatisfaction percentage in only two years. About 33 percent of respondents say they are satisfied. The poll also concluded that 82 percent of people are worried about the future of the NHS, 62 percent expect the NHS to get worse in the coming years and only 13 percent think that it will improve.
The leading concerns of the respondents included a lack of funding, the possibility that the NHS may cease to be free at the point of use, increased waiting times and a lack of attention given to the service because of Brexit.
Democrats’ push
Trump also claimed that Democrats are pushing a similar health care plan to the NHS in the United States. Democrats have devised plans ranging from a total-government "Medicare for all," also known as a single-payer health system, to a more limited "public option" that pits individual government-run plans up against private insurance for people who weren’t able to find affordable coverage in Obamacare. The latter allows Americans to gain access to government insurance alongside private health care plans.
The current version of Obamacare, more formally known as the Affordable Care Act, has little resemblance to the NHS, where the government owns most of the hospitals and clinics, and doctors and nurses are government employees.
Our ruling
Trump said, "The Democrats are pushing for Universal HealthCare while thousands of people are marching in the UK because their U system is going broke and not working. Dems want to greatly raise taxes for really bad and non-personal medical care. No thanks!"
While the NHS has lost funding over the years, the march that took place was not in opposition to the service, but a call to increase funding and stop austerity cuts towards health and social care. The march resulted because people want universal health care to work better, not because they want it taken over by the private sector.
We rate this Mostly False.

About this statement:

Published: Thursday, February 8th, 2018 at 11:00 a.m.
Researched by: Mica Soellner
Edited by: Angie Drobnic Holan

Sources:

Twitter, @realDonaldTrump tweet, Feb 5, 2018
Twitter, @realDonaldTrump tweet, Feb 5, 2018
Twitter, @jeremycorbyn tweet, Feb 5, 2018
Twitter, @Jeremy_Hunt tweet, Feb 5, 2018
The Independent, NHS cuts blamed for 30,000 deaths in new study, Feb 17, 2017
Ipsos, What do the public think about the NHS?, September 16, 2017
Interview with Thomas C. Ricketts, University of North Carolina health policy professor and deputy director of the Cecil G. Sheps Center for Health Services Research, February 6, 2018
Interview with Ian Shaw, Professor of health policy at the University of Nottingham, February 6, 2018
Interview with Christopher Newdick, professor of Health Law at the University of Reading. February 7, 2018